Aadi Bioscience Stock (NASDAQ: AADI) stock price, news, charts, stock research, profile.
Open | $2.380 |
Close | $2.340 |
Volume / Avg. | 349.284K / 426.604K |
Day Range | 2.330 - 2.450 |
52 Wk Range | 1.550 - 8.650 |
Market Cap | $56.985M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 6.13% |
Days to Cover | 4.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aadi Bioscience (NASDAQ: AADI) through any online brokerage.
Other companies in Aadi Bioscience’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Curis (NASDAQ:CRIS) and Immuneering (NASDAQ:IMRX).
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by Piper Sandler on Friday, December 15, 2023. The analyst firm set a price target for 5.00 expecting AADI to rise to within 12 months (a possible 115.44% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Aadi Bioscience (NASDAQ: AADI) is $2.3208 last updated March 28, 2024 at 4:56 PM EDT.
There are no upcoming dividends for Aadi Bioscience.
Aadi Bioscience’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Aadi Bioscience.
Aadi Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.